Geminus Therapeutics is successfully developing novel Artemesinin (ART) drugs for treatment of acute myeloid leukemia (AML).
Early Charm is a venture studio that converts science to business. We specialize in turning brilliant scientific discoveries into companies focused on growth. We don’t chase quick exits. We grow companies that create sustainable value.
1100 Wicomico St,
Baltimore, MD 21230